Nutrahelix Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 18-07-2024
- Paid Up Capital ₹ 3.00 M
as on 18-07-2024
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -11.42%
(FY 2023)
- Profit 22.30%
(FY 2023)
- Ebitda 44.71%
(FY 2023)
- Net Worth -13.53%
(FY 2023)
- Total Assets 9.06%
(FY 2023)
About Nutrahelix Biotech
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.00 M, as per Ministry of Corporate Affairs (MCA) records.
Shreenarayan Agrawal, Meena Agrawal, and Nandan Agrawal serve as directors at the Company.
- CIN/LLPIN
U01403MH2009PTC198022
- Company No.
198022
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Dec 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Nutrahelix Biotech Private Limited offer?
Nutrahelix Biotech Private Limited offers a wide range of products and services, including Ready to Eat & Instant Food Mixes, Pasta & Soups.
Who are the key members and board of directors at Nutrahelix Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nandan Agrawal  | Director | 01-Oct-2010 | Current |
| Shreenarayan Agrawal | Director | 21-Dec-2009 | Current |
| Meena Agrawal | Director | 21-Dec-2009 | Current |
Financial Performance and Corporate Structure Insights of Nutrahelix Biotech.
Nutrahelix Biotech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 11.42% decrease. The company also saw a substantial improvement in profitability, with a 22.3% increase in profit. The company's net worth observed a substantial decline by a decrease of 13.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nutrahelix Biotech?
In 2023, Nutrahelix Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nandan Petrochem LimitedActive 32 years 6 monthsShreenarayan Agrawal and Nandan Agrawal are mutual person
- Nandan Impex Pvt LtdActive 38 years 7 months
Shreenarayan Agrawal and Nandan Agrawal are mutual person
- Nandan Builders Private LimitedActive 28 years 8 months
Shreenarayan Agrawal and Meena Agrawal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nutrahelix Biotech?
Unlock and access historical data on people associated with Nutrahelix Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nutrahelix Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nutrahelix Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
